These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases. Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851 [TBL] [Abstract][Full Text] [Related]
5. Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. Rao S; Solomon N; Miller S; Dunn E J Pediatr; 1985 Nov; 107(5):685-8. PubMed ID: 4056966 [TBL] [Abstract][Full Text] [Related]
6. Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. Kim SK; Miller JH J Nucl Med; 2002 Jul; 43(7):896-900. PubMed ID: 12097459 [TBL] [Abstract][Full Text] [Related]
7. A new formulation of Tc-99m minimicroaggregated albumin for marrow imaging: comparison with other colloids, In-111 and Fe-59. McAfee JG; Subramanian G; Aburano T; Thomas FD; Fernandes P; Gagne G; Lyons B; Zapf-Longo C J Nucl Med; 1982 Jan; 23(1):21-8. PubMed ID: 6459431 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow scan evaluation of arthropathy in sickle cell disorders. Alavi A; Schumacher HR; Dorwart B; Kuhl DE Arch Intern Med; 1976 Apr; 136(4):436-40. PubMed ID: 1267551 [TBL] [Abstract][Full Text] [Related]
9. Hyperemic peripheral red marrow in a patient with sickle cell anemia demonstrated on Tc-99m labeled red blood cell venography. Heiden RA; Locko RC; Stent TR Clin Nucl Med; 1991 Mar; 16(3):153-6. PubMed ID: 2032425 [TBL] [Abstract][Full Text] [Related]
12. Significance of bone-marrow scintigraphy in aplastic anemia: concise communication. Najean Y; Le Danvic M; Le Mercier N; Pecking A; Colonna P; Rain JD J Nucl Med; 1980 Mar; 21(3):213-8. PubMed ID: 7365513 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow scintigraphy in hemopoietic depletion states. Fortýnová J; Bakos K; Pradácová J Czech Med; 1981; 4(3):137-46. PubMed ID: 7307848 [TBL] [Abstract][Full Text] [Related]
14. Failure to detect extramedullary hematopoiesis during bone-marrow imaging with indium-111 or technetium-99m sulfur colloid. Harnsberger HR; Datz FL; Knochel JQ; Taylor AT J Nucl Med; 1982 Jul; 23(7):589-91. PubMed ID: 7086530 [TBL] [Abstract][Full Text] [Related]
15. Blood flow and tracer uptake in normal and abnormal canine bone: comparisons with Sr-85 microspheres, Kr-81m, and Tc-99m MDP. Lavender JP; Khan RA; Hughes SP J Nucl Med; 1979 May; 20(5):413-8. PubMed ID: 541698 [No Abstract] [Full Text] [Related]
16. Aplastic crisis due to extensive bone marrow necrosis in sickle cell disease. Pardoll DM; Rodeheffer RJ; Smith RR; Charache S Arch Intern Med; 1982 Nov; 142(12):2223-5. PubMed ID: 7138173 [No Abstract] [Full Text] [Related]
17. Splenic uptake of both technetium-99m diphosphonate and technetium-99m sulfur colloid in sickle cell beta (0) thalassemia. Heck LL; Brittin GM Clin Nucl Med; 1989 Aug; 14(8):557-63. PubMed ID: 2805534 [TBL] [Abstract][Full Text] [Related]
18. Studies of skeletal tracer kinetics. III. Tc-99m(Sn)methylenediphosphonate uptake in the canine tibia as a function of blood flow. Sagar VV; Piccone JM; Charkes ND J Nucl Med; 1979 Dec; 20(12):1257-61. PubMed ID: 536792 [TBL] [Abstract][Full Text] [Related]
19. Bone and marrow imaging in sickle cell disease: diagnosis of infarction. Lutzker LG; Alavi A Semin Nucl Med; 1976 Jan; 6(1):83-93. PubMed ID: 1108210 [TBL] [Abstract][Full Text] [Related]